Targeting Opioid-Producing Immune Cells for Pain Control Without Addiction

Immune cells that produce and release opioid peptides at inflammation sites can be pharmacologically targeted for localized pain control — peripheral opioid analgesia without central addiction, tolerance, or sedation.

Machelska, Halina·Neuropeptides·2007·Moderate EvidenceReview
RPEP-01266ReviewModerate Evidence2007RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Review
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

Peripheral opioid analgesia from immune cell-derived peptides can be enhanced by: recruiting more opioid-producing leukocytes, increasing per-cell opioid release, or applying peripherally-restricted opioid agonists — achieving pain control without CNS side effects.

Key Numbers

How They Did This

review study on opioid-peptides, pain.

Why This Research Matters

Relevant for opioid-peptides, pain, immune-function.

The Bigger Picture

Advances peptide research.

What This Study Doesn't Tell Us

See abstract.

Questions This Raises

  • ?Further research needed.
  • ?Clinical translation to evaluate.

Trust & Context

Key Stat:
Key finding Peripheral opioid analgesia from immune cell-derived peptides can be enhanced by: recruiting more opioid-producing leukocytes, increasing per-cell opi
Evidence Grade:
moderate evidence.
Study Age:
Published in 2007.
Original Title:
Targeting of opioid-producing leukocytes for pain control.
Published In:
Neuropeptides, 41(6), 355-63 (2007)
Authors:
Machelska, Halina(7)
Database ID:
RPEP-01266

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research on a topic.

What do these levels mean? →

Frequently Asked Questions

What was studied?

Targeting Opioid-Producing Immune Cells for Pain Control Without Addiction

What was found?

Immune cells that produce and release opioid peptides at inflammation sites can be pharmacologically targeted for localized pain control — peripheral opioid analgesia without central addiction, tolerance, or sedation.

Read More on RethinkPeptides

Cite This Study

RPEP-01266·https://rethinkpeptides.com/research/RPEP-01266

APA

Machelska, Halina. (2007). Targeting of opioid-producing leukocytes for pain control.. Neuropeptides, 41(6), 355-63.

MLA

Machelska, Halina. "Targeting of opioid-producing leukocytes for pain control.." Neuropeptides, 2007.

RethinkPeptides

RethinkPeptides Research Database. "Targeting of opioid-producing leukocytes for pain control." RPEP-01266. Retrieved from https://rethinkpeptides.com/research/machelska-2007-targeting-of-opioidproducing-leukocytes

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.